Doctor Jaya Birgitte Rosenmeier
AstraZeneca, Gothenburg (Sweden)
Safety, tolerability, and pharmacokinetics of AZD5462, a small molecule agonist of the RXFP1 relaxin receptor
Event: ESC Congress 2023
Topic: Pharmacotherapy
Session: Experimental therapies for heart failure
